Ordering Recommendation

Use to detect and quantify HIV-1. Use to determine HIV-1 drug resistance by DNA sequencing.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA), pink (K2EDTA), or plasma preparation tube (PPT).

Specimen Preparation

Separate from cells within 24 hours of collection. Transfer 4 mL plasma to an ARUP standard transport tube and freeze. (Min: 2.5 mL)

Storage/Transport Temperature

Frozen

Unacceptable Conditions

Serum. Heparinized specimens.

Remarks
Stability

After separation from cells: Ambient: 24 hours (Critical: Ship FROZEN); Refrigerated: 72 hours; Frozen: 3 months

Methodology

Quantitative Transcription-Mediated Amplification (TMA)

Performed

Sun-Sat

Reported

2-14 days

Reference Interval

Test Number
Components
Reference Interval
  HIV-1 Qnt by NAAT Interp Not Detected

Interpretive Data

Refer to report

Compliance Category

FDA

Note

If Human Immunodeficiency Virus 1 by Quantitative NAAT result is greater than or equal to 2.70 log copies/mL, then HIV- Drug Resistance by Next Generation Sequencing will be added. Additional charges apply.

Hotline History

N/A

CPT Codes

87536; if reflexed add 87900; 87901; 87906

Components

Component Test Code* Component Chart Name LOINC
3000868 HIV-1 Qnt by NAAT (copies/mL) 20447-9
3000869 HIV-1 Qnt by NAAT (log copies/mL) 29541-0
3000970 HIV-1 Qnt by NAAT Interp 25835-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • HIV genotyping for drug sensitivity testing
  • HIV-1 reflex to genotyping
  • HIV-1 Treatment decision
  • HIV-1 viral load
  • Nucleic Acid Amplification Test (NAAT)
  • Viral load monitoring
Human Immunodeficiency Virus 1 (HIV-1) by Quantitative NAAT with Reflex to HIV-1 Drug Resistance by Next Generation Sequencing